Pulmonology Flashcards
Decision to hospitalize for pneumonia
Confusion Uremia (BUN > 7mmol/L) Resp rate greater than or equal to 30 BP <90 systolic/less than or equal to 60 diastolic Age greater than or equal to 65
Empirical abx recommendations in pneumonia for previously healthy pts with no abx use in prior 3 mos
Azithromycin 500 mg PO x1 dose then 250 mg PO q24h x4 days OR
Clarithromycin 500 mg PO BID or clarithro ER 1 gm PO q24h x 7days OR
Doxycycline 100 mg PO BID 5-7 days
Empirical abx recommendations in pneumonia for comorbidities
Levo 750 mg PO q24h x 5 days
Amoxicillin-clavulanate 1000/62.5 mg 2 tabs PO BID
What is considered a comorbidity for pneumonia tx?
Chronic heart, lung, liver, renal dz DM Alcoholism CA Asplenia Immunosuppression Recent abx use
Empirical abx recommendations in pneumonia for areas with high rate (>25%) macrolide-resistant S. pneumoniae
Choose alternative
What are suggestive findings of an “atypical” pneumonia?
No clinical or laboratory features reliable distinguish from typical
Little sputum
Not “consolidating” (CXR, ausculatation)
Poor response to beta-lactams
Mild, intermittent asthma
Day sx 2x/wk
Night sx 2x/mo or less
Lungs fine between attacks
Mild, persistent asthma
Day sx 2+/wk
Night sx 2+/mo
Interfere with daily activities
Moderate, persistent asthma
Day sx daily
Night sx 1+/wk
Interfere with daily activities
Severe, persistent asthma
Day sx daily
Night sx frequent
Daily activities limited
What is the maximum amount of usage for a SABA?
No more than 3-4 times/day
Step 1 asthma tx
For intermittent asthma
SABA
Step 2 asthma tx
For mild persistent asthma
SABA
Low-dose ICS
Alternatives: Sustained-release theophylline or cromone or leukotriene modifier
Step 3 asthma tx
For moderate persistent asthma SABA Low-to-medium dose ICS + LABA Alternatives: Medium-dose ICS + sustained-release theophylline OR Medium-dose ICS + LABA OR High-dose ICS OR Medium-dose ICS + leukotriene modifier
Step 4 asthma tx
For severe persistent asthma High-dose ICS + one or more of the following, if needed: Sustained-release theophylline Leukotriene modifier LABA Oral glucocorticosteroid
Presentation of controlled asthma
Nl physical activity
SABA use < 4x/wk
Daytime sx < 4 days/wk
Nighttime sx <1 night/wk
Presentation of uncontrolled asthma
Some interruption with activities
SABA use 4 or more x/wk
Daytime sx 4 or more days/wk
Nighttime sx 1 or more nights/wk
Presentation of dangerously uncontrolled asthma
Difficulty talking Reliever inhaler does work as usual OR Relief lasts < 2hrs Daytime sx all the time Nighttime sx every night
Examples of SABAs
Salbutamol
Fenoterol
Examples of anticholinergics for asthma
Ipratropium bromide
Tiotropium